We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Attempts to improve efficacy by administering anabolicagents and bisphosphonates concomitantly have been unsuccessful.
2
Clinical trials are needed to determine the long-term effectiveness and safety of novel anabolicagents for the management of osteoporosis.
3
In osteoporotic patients treated with anabolicagents, a Ca-Pi supplement appears to be preferable to carbonate or citrate Ca salt.
4
Evidence was found in the final analysis that anabolicagents were present in the supplements in sufficient amounts to cause a positive test.
5
By virtue of their secretory status, some vibe proteins may be candidates for pre-clinical development as anabolicagents for the treatment of osteoporosis.